UA
32
8
VRSN
53
-2
AIV
71
9
FDX
29
-21
EBAY
47
-2
PEP
47
-3
PNC
57
-2
EOG
42
-8
BF.B
43
-7
MAR
60
7
FLS
56
-3
GPC
37
-14
CNX
80
4
AAP
24
-2
HP
41
-4
ILMN
41
-3
NEM
48
2
MOS
19
-4
CHD
54
6
AVY
53
-9
UA
32
8
VRSN
53
-2
AIV
71
9
FDX
29
-21
EBAY
47
-2
PEP
47
-3
PNC
57
-2
EOG
42
-8
BF.B
43
-7
MAR
60
7
FLS
56
-3
GPC
37
-14
CNX
80
4
AAP
24
-2
HP
41
-4
ILMN
41
-3
NEM
48
2
MOS
19
-4
CHD
54
6
AVY
53
-9
Financhill
Back

Autolus Therapeutics PLC Quote, Financials, Valuation and Earnings

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30

AUTL
Autolus Therapeutics PLC

Last Price:
3.72
Seasonality Move:
-0.23%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Autolus Therapeutics PLC Price Quote

$3.72
-0.01 (-3.25%)
(Updated: September 21, 2024 at 6:12 AM ET)

Autolus Therapeutics PLC Key Stats

Sell
30
Autolus Therapeutics PLC (AUTL) is a Sell
Day range:
$3.64 - $3.86
52-week range:
$2.01 - $7.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.88%
Volume:
747.5K
Avg. volume:
638K
1-year change:
34.66%
Market cap:
$992.5M
Revenue:
$1.7M
EPS:
$-1.17

How Much Does Autolus Therapeutics PLC Make?

Data Unavailable

Is Autolus Therapeutics PLC Growing As A Company?

Data Unavailable

Autolus Therapeutics PLC Stock Price Performance

What Is Autolus Therapeutics PLC 52-Week High & Low?

Autolus Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Autolus Therapeutics PLC?

Is Autolus Therapeutics PLC Cash Flow Positive?

  • What Is AUTL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$156.6M
  • What Is Autolus Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $559.4M
  • What Is Autolus Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.3M

Autolus Therapeutics PLC Return On Invested Capital

Data Unavailable

Autolus Therapeutics PLC Earnings Date & Stock Price

Autolus Therapeutics PLC Competitors

Autolus Therapeutics PLC Dividend Yield

Autolus Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -7%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 10.22
Upside from Last Price: 174.05%

Major Shareholders

  • How many AUTL shares are owned by institutional investors?
    201.3M AUTL shares are owned by institutional investors
  • How many AUTL shares are owned by insiders?
    0 AUTL shares are owned by insiders